000 | 01752 a2200541 4500 | ||
---|---|---|---|
005 | 20250516002250.0 | ||
264 | 0 | _c20110202 | |
008 | 201102s 0 0 eng d | ||
022 | _a2040-3372 | ||
024 | 7 |
_a10.1039/c0nr00161a _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDe Angelis, F | |
245 | 0 | 0 |
_aWater soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor context. _h[electronic resource] |
260 |
_bNanoscale _cOct 2010 |
||
300 |
_a2230-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 |
_aB-Lymphocytes _xdrug effects |
650 | 0 | 4 |
_aBiocompatible Materials _xchemistry |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aDrug Carriers _xchemistry |
650 | 0 | 4 | _aDrug Delivery Systems |
650 | 0 | 4 |
_aDrug Screening Assays, Antitumor _xmethods |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHydrophobic and Hydrophilic Interactions |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 |
_aNanostructures _xchemistry |
650 | 0 | 4 |
_aNanotechnology _xmethods |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 |
_aWater _xchemistry |
700 | 1 | _aPujia, A | |
700 | 1 | _aFalcone, C | |
700 | 1 | _aIaccino, E | |
700 | 1 | _aPalmieri, C | |
700 | 1 | _aLiberale, C | |
700 | 1 | _aMecarini, F | |
700 | 1 | _aCandeloro, P | |
700 | 1 | _aLuberto, L | |
700 | 1 | _ade Laurentiis, A | |
700 | 1 | _aDas, G | |
700 | 1 | _aScala, G | |
700 | 1 | _aDi Fabrizio, E | |
773 | 0 |
_tNanoscale _gvol. 2 _gno. 10 _gp. 2230-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1039/c0nr00161a _zAvailable from publisher's website |
999 |
_c20166402 _d20166402 |